Join us! We are hiring both a Senior Scientist and a Scientist

Join us when we are expanding. We are now looking for both a Senior Scientist and a Scientist with experience and interest in drug development in the late clinical phase.  Join us in our work to give people worldwide a longer and better life. We are an entrepreneurial company and experts in global vaccine development, manufacturing, […]

Guest editor for Stockholm Science City on Instagram

This week, 23rd – 27th January, Scandinavian Bioharma is the guest editor for Stockholm Science City on Instagram, @sthlmscicity. Please join us, we have an exciting week in front of us!

New ETVAX® data was presented during VASE, an international gathering dedicated to develop Shigella and ETEC vaccines

During three days in Washington, the top minds in the enteric vaccine field met to share the latest research and ideas toward making enteric vaccines a reality to advance global health. Scandinavian Biopharma was playing a key role sharing important research and development advancements. The Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference brings […]

Scandinavian Biopharma welcomes Johan Jarmander to the position as Drug Substance Specialist Manufacturing & Development

Scandinavian Biopharma continues to strengthen its organization in manufacturing and is pleased to welcome Johan Jarmander as our new Drug Substance Specialist Manufacturing & Development. Johan holds a doctorate degree in biotechnology from the KTH Royal Institute of Technology and has extensive experience from manufacturing of biological medicinal products. Johan comes most recently from Octapharma […]

Scandinavian Biopharma enters into a commercial collaboration with Novavax in Sweden

Scandinavian Biopharma and Novavax have signed a commercial collaboration agreement for the Covid vaccine Nuvaxovid. Nuvaxovid is an adjuvanted protein-based vaccine that protects against SARS Covid-19. Scandinavian Biopharma has extensive experience in the sale and marketing of vaccines. As of October 2022, the company is the representative for Nuvaxovid on the Swedish market and will […]



Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.